# Tirzepatide Recall: What It Means and What to Do **By TelosRX Editorial Team** · 2026-10-27 **A tirzepatide recall means specific lots of a tirzepatide product were pulled because of a quality or safety concern, often sterility. It doesn't mean every vial is unsafe. Check your lot number, then contact your pharmacy or [TelosRX](https://telosrx.com).** Search interest in "tirzepatide recall" jumped this month. So did searches for "tirzepatide compounded vials safety concern." If you saw a headline and looked at your fridge with suspicion, you're not alone. This explainer covers what a tirzepatide recall actually is, how FDA classifies recalls, and how to check whether your vial is affected. It also covers what to do next, step by step, without panic. ## What a Tirzepatide Recall Actually Means A drug recall is the removal or correction of a product that has a problem. The problem might be contamination, a labeling error, or a failed quality test. Most recalls are voluntary, started by the company that made or distributed the product. The key word is **specific**. A recall names exact products, strengths, and lot numbers. A lot (one production batch) gets its own code on the label. If your lot isn't listed, your vial isn't part of that recall. Recalls are also a sign the safety system is working. Someone found a problem and flagged it. That's the point of the process. ## Why Compounded Tirzepatide Vials Get Recalled Injectable medications must be sterile. That means free of bacteria, fungi, and other microbes. When a compounder can't prove sterility, the product can be recalled even if no contamination has been found. FDA keeps a running list of [compounding inspections, recalls, and other actions](https://www.fda.gov/drugs/human-drug-compounding/compounding-inspections-recalls-and-other-actions). Recent entries and warning letters describe recalls of compounded tirzepatide multidose vials over a "lack of assurance of sterility." That phrase is common. It usually points to process problems, not confirmed infections. Common reasons a compounded injectable gets recalled include: - **Sterility assurance gaps** — clean-room or testing processes didn't meet standards. - **Failed sterility or endotoxin tests** — endotoxins are fever-causing bacterial fragments. - **Potency problems** — the vial holds more or less drug than the label says. - **Labeling errors** — wrong strength, wrong dates, or missing information. - **Unapproved additives** — mixes with ingredients that haven't been studied together. ## The October 2026 Tirzepatide Recall, Briefly In October 2026, national news outlets reported an FDA Class II classification for a voluntary recall of compounded tirzepatide multidose vials from one compounding company. The stated concern was that sterility could not be assured. Reports said the affected product was a limited set of lots distributed nationwide. Reports also noted that brand-name Mounjaro and Zepbound were not part of that recall. That matches a frequent question in search right now: "is compounded tirzepatide the same as Zepbound?" It isn't. Zepbound and Mounjaro are FDA-approved products. Compounded tirzepatide is not FDA-approved. Details like lot numbers can change as FDA updates its records. Always check the current notice, not a screenshot or a social post. ## How FDA Classifies a Recall FDA sorts recalls into three classes by risk. The definitions come from FDA's [recalls background and definitions](https://www.fda.gov/safety/industry-guidance-recalls/recalls-background-and-definitions) page. Recall class What FDA means What it means for you **Class I** Reasonable probability the product could cause serious health problems or death Stop using it and contact your pharmacy and provider promptly **Class II** May cause temporary or medically reversible problems; serious harm is remote Check your lot, set affected vials aside, and get a replacement plan **Class III** Not likely to cause adverse health effects Usually a labeling or minor quality issue; follow pharmacy instructions **Market withdrawal** A minor issue that FDA wouldn't take legal action over Typically no action needed beyond what your pharmacy advises Class II is the most common class for drug recalls. It still deserves action. It just isn't a reason for panic. ## How to Check If Your Tirzepatide Vial Is Affected This takes about five minutes. Grab your vial and its box or pharmacy label. 1. **Find the lot number.** It's usually printed near the beyond-use date (BUD), the date after which a compounded product shouldn't be used. 2. **Note the pharmacy name and strength.** Recalls are tied to a specific compounder and concentration. 3. **Compare against the official notice.** Use FDA's compounding actions list or the recall notice your pharmacy sends. 4. **Match all three details.** Pharmacy, strength, and lot number must all line up. 5. **If it matches, set it aside.** Don't throw it out yet. Your pharmacy may ask for it back. If you get your medication through [TelosRX tirzepatide care](https://www.telosrx.com/pages/tirzepatide), your label lists the dispensing pharmacy, lot, and BUD. Send the care team a secure message with a photo of the label. Our asynchronous model means you don't need to book a call. A clinician reviews your message and replies. ## What to Do If Your Vial Is Recalled Don't make dosing decisions alone. Stopping, restarting, or switching products can change how you feel. That's especially true with GI side effects after a gap in doses. - **Pause use of the affected vial** and contact the pharmacy that dispensed it. - **Message your prescribing provider.** Ask how to bridge any gap and when to restart. - **Ask about a replacement.** Any new prescription is subject to medical approval by a licensed provider. - **Keep the vial and packaging** until the pharmacy tells you what to do with it. - **Report problems.** You can file a report through FDA's [MedWatch program](https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program). ## Warning Signs to Watch for After an Injection Most people who used a vial later recalled for sterility assurance never notice anything. Still, know the signs of an injection-site infection. Seek medical care promptly if you notice: - Redness or warmth that spreads or worsens after the first day - Swelling, a hard lump, or pus at the injection site - Fever, chills, or feeling unusually unwell - Severe pain at the site that keeps getting worse Mild redness that fades within a day is a common injection reaction. Spreading redness with fever is not. When in doubt, get checked. ## How to Lower Your Risk With Any Tirzepatide Vial You can't control a compounder's clean room. You can control what happens after the vial reaches your door. - **Use a licensed pharmacy** and a real prescription. Skip "research use only" sellers. - **Inspect every vial.** Don't use it if it looks cloudy, discolored, or has particles, unless your label says otherwise. - **Respect the BUD.** Searches like "how long is tirzepatide good for in the fridge" are common. The answer is on your label, not a forum. - **Store it correctly.** See our guide on [how to store tirzepatide](https://www.telosrx.com/blogs/glp1/how-to-store-tirzepatide-guide). - **Use clean technique.** Fresh needle, alcohol swab on the stopper, every time. Shipping matters too. If a box shows up warm, read [what to know if your shipment arrives warm](https://www.telosrx.com/blogs/glp1/semaglutide-or-tirzepatide-shipment-arrives-warm) before you use it. ## Compounded vs Brand-Name Tirzepatide: What's Different Brand-name tirzepatide (Mounjaro, Zepbound) is FDA-approved and made under drug manufacturing rules. Compounded tirzepatide is prepared by a pharmacy for an individual patient's prescription. It is not FDA-approved, which means FDA hasn't reviewed that specific preparation for safety, effectiveness, or quality. That difference doesn't make every compounded product risky. It does make pharmacy quality the whole ballgame. For a deeper look, read [what compounded tirzepatide is](https://www.telosrx.com/blogs/glp1/what-is-compounded-tirzepatide). If you're weighing options, our [GLP-1 options page](https://www.telosrx.com/pages/glp-1-options) lays out what's available, subject to provider approval. ## Frequently Asked Questions ### Is there a tirzepatide recall right now? In October 2026, news outlets reported an FDA Class II classification for a recall of compounded tirzepatide multidose vials from one compounder over sterility assurance. Recalls apply only to listed lots. Check FDA's compounding actions page or your pharmacy's notice for the current list, since details can be updated after first reports. ### Are Zepbound or Mounjaro part of the tirzepatide recall? Reports on the October 2026 recall said brand-name Mounjaro and Zepbound were not included. That recall involved compounded vials from a single compounding company. Brand products have their own lot numbers and manufacturer. If you use a brand product, check the manufacturer's site or FDA's recall listings for any notice about your specific lot. ### What should I do if my tirzepatide vial is recalled? Stop using the affected vial and set it aside. Contact the dispensing pharmacy and your prescriber. Ask how to handle the gap in doses and whether a replacement is appropriate, which is subject to provider approval. Keep the vial and packaging until the pharmacy gives instructions. Report any side effects through FDA MedWatch. ### How do I find the lot number on my tirzepatide vial? The lot number is usually printed on the vial label and the outer box, often next to the beyond-use or expiration date. It may be labeled Lot or LOT. Match it with the pharmacy name and strength listed in the recall notice. All three details need to line up for your vial to be affected. ### Can a recalled tirzepatide vial make you sick? Many recalls happen because sterility can't be assured, not because contamination was confirmed. Most people never notice a problem. Still, a contaminated injectable can cause infection. Watch for spreading redness, swelling, pus, fever, or chills after an injection, and seek medical care promptly if any of those appear. ### Is compounded tirzepatide FDA-approved? No. Compounded tirzepatide is not FDA-approved. It is prepared by a licensed pharmacy for an individual prescription. Mounjaro and Zepbound are the FDA-approved tirzepatide products. Because compounded preparations aren't reviewed by FDA individually, the quality standards of the dispensing pharmacy matter a great deal. _TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._ Start your private evaluation at [TelosRX](https://telosrx.com). **Tags:** compounded tirzepatide, drug recall classes, explainer, GLP-1, medication safety, tirzepatide recall --- > Source: [Telos RX](https://www.telosrx.com/blogs/glp1/tirzepatide-recall-explained)